Showing 1 - 20 results of 30 for search 'Yoshiya Tanaka', query time: 0.03s Refine Results
  1. 1
    Real-World Safety and Efficacy of Targeted Therapies in Rheumatoid Arthritis: A 5-Year, 5130-Case Follow-Up from FIRST Registry

    Real-World Safety and Efficacy of Targeted Therapies in Rheumatoid Arthritis: A 5-Year, 5130-Case Follow-Up from FIRST Registry by Koshiro Sonomoto, Shingo Nakayamada, Hiroaki Tanaka, Atsushi Nagayasu, Yoshiya Tanaka

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Early effects of ozoralizumab 30 mg in patients with rheumatoid arthritis and inadequate response to methotrexate: a post hoc trajectory analysis of the phase II/III OHZORA trial

    Early effects of ozoralizumab 30 mg in patients with rheumatoid arthritis and inadequate response to methotrexate: a post hoc trajectory analysis of the phase II/III OHZORA trial by Tsutomu Takeuchi, Yoshiya Tanaka, Yusuke Miyazaki, Nobuko Horiuchi, Shunsuke Okamoto, Rumiko Matsumoto

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    The Lupus Check 5 Tool: A Practical Approach to Initiating Treatment Reviews in Systemic Lupus Erythematosus

    The Lupus Check 5 Tool: A Practical Approach to Initiating Treatment Reviews in Systemic Lupus Erythematosus by Anca Askanase, Antonis Fanouriakis, Lyra Agustin, Maria Dall’Era, Marta Mosca, Yoshiya Tanaka

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Effect of Ozoralizumab Administration with or without Methotrexate in Patients with Rheumatoid Arthritis: A Post-Hoc Analysis

    Effect of Ozoralizumab Administration with or without Methotrexate in Patients with Rheumatoid Arthritis: A Post-Hoc Analysis by Yoshiya Tanaka, Nobuko Horiuchi, Cosmo Sasajima, Rumiko Matsumoto, Masafumi Kawanishi, Saeko Uchida, Tsutomu Takeuchi

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Association of peripheral CD8+ T cell activation with disease activity and treatment resistance in systemic lupus erythematosus

    Association of peripheral CD8+ T cell activation with disease activity and treatment resistance in systemic lupus erythematosus by Yoshiya Tanaka, Hiroaki Tanaka, Satoshi Kubo, Yuya Fujita, Shingo Nakayamada, Yusuke Miyazaki, Koshiro Sonomoto

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Filgotinib Radiographic and Clinical Efficacy Versus Other JAK Inhibitors and Adalimumab in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate: A Systematic Review and Network Meta-Analysis

    Filgotinib Radiographic and Clinical Efficacy Versus Other JAK Inhibitors and Adalimumab in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate: A Systematic... by Yoshiya Tanaka, Rene Westhovens, Hong Sun, Carole Van der Donckt, Yan Zhong, Toshihiko Kaise

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    The Uncoupling of Disease Activity from Joint Structural Progression in Patients with Rheumatoid Arthritis Treated with Filgotinib

    The Uncoupling of Disease Activity from Joint Structural Progression in Patients with Rheumatoid Arthritis Treated with Filgotinib by Yoshiya Tanaka, Tatsuya Atsumi, Daniel Aletaha, Hendrik Schulze-Koops, Haruhiko Fukada, Chris Watson, Tsutomu Takeuchi

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Trajectory analysis of glucocorticoid treatment highlights issues in the current tapering strategy for polymyalgia rheumatica

    Trajectory analysis of glucocorticoid treatment highlights issues in the current tapering strategy for polymyalgia rheumatica by Yoshiya Tanaka, Toshiya Takahashi, Toshiki Fukasawa, Shoichiro Inokuchi, Hidetoshi Uenaka, Akiko Fujita, Koji Shimamoto, Kazuhito Sakamoto

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Safety, pharmacokinetics, biomarker response and efficacy of E6742: a dual antagonist of Toll-like receptors 7 and 8, in a first in patient, randomised, double-blind, phase I/II study in systemic lupus erythematosus

    Safety, pharmacokinetics, biomarker response and efficacy of E6742: a dual antagonist of Toll-like receptors 7 and 8, in a first in patient, randomised, double-blind, phase I/II st... by Tomonori Ishii, Yoshiya Tanaka, Atsushi Kumanogoh, Tatsuya Atsumi, Shizuo Akira, Fumitoshi Tago, Mari Aoki, Shintaro Yamamuro

    Published 2024-09-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Low rates of radiographic progression of structural joint damage over 2 years of baricitinib treatment in patients with rheumatoid arthritis

    Low rates of radiographic progression of structural joint damage over 2 years of baricitinib treatment in patients with rheumatoid arthritis by Désirée van der Heijde, Yoshiya Tanaka, Paul Emery, Li Xie, Michael Schiff, Gabriella Meszaros, Taeko Ishii, Marta Casillas, Robert A Ortmann

    Published 2019-06-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Critical roles of IL-6 signaling in myoblast differentiation of human adipose-derived mesenchymal stem cells

    Critical roles of IL-6 signaling in myoblast differentiation of human adipose-derived mesenchymal stem cells by Takashi Otsuka, Kaoru Yamagata, Mai-Phuong Nguyen, Uyen Thi Ngo, Hidenori Sakai, Gulzhan Trimova, Junpei Anan, Yosuke Okada, Shingo Nakayamada, Yoshiya Tanaka

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Efficacy and safety of upadacitinib as monotherapy or combined with elsubrutinib for the treatment of systemic lupus erythematosus: results through 104 weeks in a long-term extension study

    Efficacy and safety of upadacitinib as monotherapy or combined with elsubrutinib for the treatment of systemic lupus erythematosus: results through 104 weeks in a long-term extensi... by Joan T Merrill, Yoshiya Tanaka, Amit Saxena, Xiaofeng Zeng, Martin Aringer, David D’Cruz, Kristin M D’Silva, Ling Cheng, Thao T Doan, Karim R Masri

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Regulation of fibronectin and collagens type I, III and VI by TNF-α, TGF-β, IL-13, and tofacitinib

    Regulation of fibronectin and collagens type I, III and VI by TNF-α, TGF-β, IL-13, and tofacitinib by Frederik S. Gillesberg, Martin Pehrsson, Anne-Christine Bay-Jensen, Peder Frederiksen, Morten Karsdal, Bent W. Deleuran, Tue W. Kragstrup, Satoshi Kubo, Yoshiya Tanaka, Joachim H. Mortensen

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Association of Glycaemia Risk Index With Indices of Atherosclerosis: A Cross‐Sectional Study

    Association of Glycaemia Risk Index With Indices of Atherosclerosis: A Cross‐Sectional Study by Keiichi Torimoto, Yosuke Okada, Tomoya Mita, Kenichi Tanaka, Fumiya Sato, Naoto Katakami, Hidenori Yoshii, Keiko Nishida, Yoshiya Tanaka, Ryota Ishii, Masahiko Gosho, Iichiro Shimomura, Hirotaka Watada

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Upadacitinib as monotherapy in patients with rheumatoid arthritis and prior inadequate response to methotrexate: results at 260 weeks from the SELECT-MONOTHERAPY randomised study

    Upadacitinib as monotherapy in patients with rheumatoid arthritis and prior inadequate response to methotrexate: results at 260 weeks from the SELECT-MONOTHERAPY randomised study by Josef S Smolen, Yoshiya Tanaka, Paul Emery, Manish Jain, Koji Kato, Stanley B Cohen, Nasser Khan, William Rigby, Sebastian Meerwein, Juan Ignacio Vargas, Kyle M Carter, Charles Phillips

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Induction of interleukin 21 receptor expression via enhanced intracellular metabolism in B cells and its relevance to the disease activity in systemic lupus erythematosus

    Induction of interleukin 21 receptor expression via enhanced intracellular metabolism in B cells and its relevance to the disease activity in systemic lupus erythematosus by Yoshiya Tanaka, Satoshi Kubo, Hiroko Miyata, Shingo Nakayamada, Kaoru Yamagata, Yusuke Miyazaki, Ippei Miyagawa, Shigeru Iwata, Ryuichiro Kanda, Koshiro Sonomoto, Yasuyuki Todoroki, Masanobu Ueno, Atsushi Nagayasu, Takafumi Aritomi

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Influence of Rheumatoid Factors on the Efficacy of TNF Inhibitor Therapy in Patients with Rheumatoid Arthritis

    Influence of Rheumatoid Factors on the Efficacy of TNF Inhibitor Therapy in Patients with Rheumatoid Arthritis by Atsushi Nagayasu, Yusuke Miyazaki, Koshiro Sonomoto, Satoshi Kubo, Ippei Miyagawa, Ayako Yamaguchi, Hiroaki Tanaka, Yasuyuki Todoroki, Masanobu Ueno, Takafumi Aritomi, Yuya Fujita, Hidenori Sakai, Katsunori Suzuki, Shingo Nakayamada, Yoshiya Tanaka

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies

    Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies by Philip J. Mease, Joseph F. Merola, Yoshiya Tanaka, Laure Gossec, Iain B. McInnes, Christopher T. Ritchlin, Robert B. M. Landewé, Akihiko Asahina, Barbara Ink, Andrea Heinrichs, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Laura C. Coates

    Published 2024-08-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Correction: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies

    Correction: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies by Philip J. Mease, Joseph F. Merola, Yoshiya Tanaka, Laure Gossec, Iain B. McInnes, Christopher T. Ritchlin, Robert B. M. Landewé, Akihiko Asahina, Barbara Ink, Andrea Heinrichs, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Laura C. Coates

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Summary of Research: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies

    Summary of Research: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies by Philip J. Mease, Joseph F. Merola, Yoshiya Tanaka, Laure Gossec, Iain B. McInnes, Christopher T. Ritchlin, Robert B. M. Landewé, Akihiko Asahina, Barbara Ink, Andrea Heinrichs, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Laura C. Coates

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: